Loading
Latest filing published 22 Oct 2026 for KESTRA MEDICAL TECHNOLOGIES, LTD., €1.5M.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Traci S. Umberger appears in our data through filings on Kestra Medical Technologies, Ltd. shares, published by SEC (Form 4). Between 7 March 2025 and 21 October 2026, the trades on record add up to 11 filings.
The open-market side counts 1 purchase for €213k alongside 7 sales for €3.2M. On balance, insiders were net sellers of €3.0M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 share grants and 1 option exercise. In 2026 alone, the filings show no purchases and 6 sales.
Most recently, on 22 October 2026, the filings show an option exercise worth €1.5M in Kestra Medical Technologies, Ltd. The last purchase on record was published on 15 September 2025, which is 404 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations